Washington D.C. – Hopes for an imminent Federal Reserve interest rate cut have significantly dimmed following the release of hotter-than-expected Producer Price Index (PPI) data on August 14, 2025. The July PPI report revealed a surprising surge in wholesale inflation, forcing traders and economists to reconsider the widespread expectation of
MetLife’s second quarter was marked by a 2.9% negative market reaction, reflecting investor concerns over results that fell short of Wall Street expectations. Management cited less favorable underwriting, especially in Group Benefits, and lower variable investment income as primary headwinds. CEO Michel Khalaf described the underwriting experience as “within normal fluctuations,” but acknowledged challenges in both life and non-medical health, while also noting strong momentum in Asia and Latin America. The quarter was further impacted by a handful of large disability claims, which management downplayed as non-recurring.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Global insurance giant MetLife (NYSE:MET) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 4.1% year on year to $17.92 billion. Its non-GAAP profit of $2.02 per share was 6.3% below analysts’ consensus estimates.
Insurance and annuity provider Brighthouse Financial (NASDAQ:BHF) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 2.9% year on year to $2.15 billion. Its non-GAAP profit of $3.43 per share was 21.8% below analysts’ consensus estimates.
This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial results. These earnings calls are crucial events for investors, analysts, and the broader market, as they provide insights into corporate
Global insurance giant MetLife (NYSE:MET) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 7.2% year on year to $17.34 billion. Its non-GAAP profit of $2.02 per share was 6.3% below analysts’ consensus estimates.
U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove divergent moves in heavyweight names.
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.
MetLife Q2 2025 earnings miss estimates with $2.02 EPS and $17.92B revenue, triggering a 6% stock drop. Weak underwriting, lower investment income, and derivative losses drove the decline.
U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Over the past six months, MetLife’s stock price fell to $77.68. Shareholders have lost 10.7% of their capital, which is disappointing considering the S&P 500 has climbed by 5%. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Over the past six months, MetLife’s stock price fell to $77.79. Shareholders have lost 10.5% of their capital, which is disappointing considering the S&P 500 has climbed by 5.8%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life insurance industry, including Brighthouse Financial (NASDAQ:BHF) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at MetLife (NYSE:MET) and the best and worst performers in the life insurance industry.
